
A comprehensive examination of what we know to be facts about fenbendazole and cancer, including the academic and medical evidence, practical realities, financial costs, and unknowns. This information is not medical advice, and I am not a doctor.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 82 | Founded | 3 months ago | Last Issue | 4 days ago |
| Active | |||||

Focus:
Brain Tumors (Glioblastoma): Using lipid systems capable of crossing the blood-brain barrier to target aggressive, temozolomide-resistant cerebral tumors.
Colorectal Cancer: Bypassing traditional therapy resistance by local...
In translational medicine, we often view progress as a linear race to invent something entirely “new.” However, some of the most profound breakthroughs in oncology come from looking backward at the medicines already in our cabinets. This is...
This week’s live Q&A with Joe Tippens. The full recording is now available: https://mycancerstory.rocks/joe-tippens-livestream-august-20th-2026-2pmcst-joe-answers-your-questions-about-his-story/
This was a sanctioned livestream with...
The landscape of modern oncology is defined by an increasingly unsustainable “Innovation Gap.” As demand for curative therapies grows, the traditional pharmaceutical pipeline remains a...
Objective—Mebendazole and other anti-parasitic drugs are being used off-prescription based on social media and unofficial accounts of their anti-cancer activity. The purpose of this study was to conduct a controlled evaluation of mebendazol...
Subscribers, engagement, traffic and sponsorship for Fenbendazole & Cancer.
| Subscribers | Engagement | 77 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #109 |
The writers behind this newsletter.
A comprehensive examination of what we actually know about Fenbendazole and cancer, including the science, the evidence, the practical realities, and the unknowns. Everything here is for education and information only, not medical advice.
You can find recent issues that have been published by Fenbendazole & Cancer on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Fenbendazole & Cancer, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Fenbendazole & Cancer as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Fenbendazole & Cancer using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Fenbendazole & Cancer. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.